Purpose or Objective: Automated planning (AP) aims to simplify the treatment planning process by eliminating user variability. We performed a detailed plan comparison based on clinical objectives and dose-volume histogram (DVH) parameters in a group of stereotactic body radiation therapy (SBRT) lung cancer patients.
Material and Methods:
Between March 2012 and May 2015, 55 lung cancer patients were treated with SBRT at our institution. A total dose of 60 Gy in 3 fractions was prescribed to the PTV (D95). For each patient, an IMRT plan was created using in-house developed optimization software by manually tweaking a set of optimization objectives during several iterations. Final dose calculation was performed in Pinnacle 9.8 (Philips Medical Systems Inc, USA). These plans are further referred to as the manual plans (MP). For each patient, an additional plan was created retrospectively using the Pinnacle 9.10 Auto-Planning software with a template representing the clinical objectives for the following structures: GTV, PTV, lungs minus GTV, spinal cord, esophagus, heart, aorta, trachea, main stem bronchus and chest wall. Using automatic optimization tuning methods, an automated plan (AP) was created for each patient using the same IMRT beam directions as for the MP. No additional manual tweaking whatsoever was performed. For all of the above-mentioned structures the following DVH parameters were included in our analysis: D99, D98, D95, D90, D50, D5, D2 (in which xx% of the PTV volume receives a dose of at least Dxx) and Dmean. For the organs at risk (OAR) V5, V10 and V20 were also included (in which Vxx is the volume receiving at least xx Gy). The acceptability of each plan was judged against our clinical objectives (result: pass, minor deviation or fail). Additionally, pairwise comparisons of the DVH parameters were performed using paired, two-sided t-tests between the MPs and APs.
Results: Three APs failed in terms of our clinical objectives (1 plan: heart D2, 2 plans: chest wall D2), while 13 plans showed a minor deviation (12 plans: lungs minus GTV V20, 1 plan: chest wall D2). None of the MPs failed our clinical objectives, but 9 also showed a minor deviation (8 plans: lungs minus GTV V20, 1 plan: PTV D99). The graph shows average values over all patients of the dose (in Gy) -volume (in %) parameters for which statistically significant (p < 0,05) differences were found between the MPs and APs. Top: GTV and PTV; bottom: clinical OAR objectives. All plans were normalized to PTV D95 = 60 Gy.
Conclusion:
Without user intervention, AP resulted in plans that comply with our clinical objectives for almost all patients. Some APs may require slight additional manual tweaking. From a statistical point of view, AP delivers significantly less dose to the OARs, while preserving target coverage. In the near future, all plans will be blindly evaluated by three experienced radiation oncologists to assess the clinical significance of the observed statistical differences.
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